SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 189.93+0.5%Jan 2 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dwc who wrote (26820)12/8/1998 5:42:00 PM
From: Henry Niman   of 32384
 
CNBC just did a review. Noted that it was the 3rd European merger in a few months (HOE/RP and Sanofi/Synthelabo happened last month).

Hemant Shah indicated that both companies were research driven and highly focused. Astra was losing patent protection and the new company would have $13 Billion in sales in 1999 treating cancer, ulcers, and respiratory problems.

Shah indicated more mergers were inevitable because that was the only way that $100-$200 Billion companies could generate 20-30% growth rates.

Large US companies not likely to merge were said to be PFE, WRK, and WLA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext